tiprankstipranks
Trending News
More News >
Adentra Inc. (TSE:ADEN)
:ADEN
Advertisement

ADENTRA (ADEN) AI Stock Analysis

Compare
117 Followers

Top Page

TSE:ADEN

ADENTRA

(OTC:ADEN)

Rating:72Outperform
Price Target:
C$36.00
▲(3.27% Upside)
ADENTRA's overall stock score reflects a stable financial position with strong cash flow and effective cost management. Positive technical momentum and strategic earnings call insights contribute to the score, despite valuation concerns and market challenges.

ADENTRA (ADEN) vs. iShares MSCI Canada ETF (EWC)

ADENTRA Business Overview & Revenue Model

Company DescriptionADENTRA (ADEN) is a leading manufacturer and distributor of building products and materials, primarily serving the North American residential and commercial construction markets. The company operates in various sectors, including windows, doors, and other structural components, focusing on innovation and sustainability in its offerings. With a robust portfolio of high-quality products, ADENTRA aims to meet the diverse needs of builders, contractors, and homeowners.
How the Company Makes MoneyADENTRA generates revenue through the sale of its building products, which include windows, doors, and other related materials. The company's revenue model is primarily based on direct sales to contractors, builders, and distributors in the construction industry. Key revenue streams include bulk sales to large construction projects, retail sales through partnerships with home improvement stores, and custom orders for specialized building products. Additionally, ADENTRA benefits from strategic partnerships with suppliers and distributors, enhancing its market reach and operational efficiency. The company also invests in innovation and product development to capture new market segments and increase its competitive advantage.

ADENTRA Earnings Call Summary

Earnings Call Date:Aug 06, 2025
(Q2-2025)
|
% Change Since: 18.01%|
Next Earnings Date:Nov 05, 2025
Earnings Call Sentiment Neutral
ADENTRA demonstrated resilience with strong financial performance, effective cost management, and successful integration of recent acquisitions. However, challenges remain with a soft residential construction market, increased leverage, and a decline in July sales.
Q2-2025 Updates
Positive Updates
Strong Q2 Financial Performance
ADENTRA delivered sales of $597 million, adjusted EBITDA of $54 million, and adjusted EPS of $0.88. Sales increased nearly 9% compared to last year.
Successful Acquisition Integration
The acquisition of Woolf Distributing contributed significantly to revenue growth, enhancing ADENTRA's presence in the U.S. Midwest and introducing new specialty products.
Effective Cost Management
Operating expenses were up less than 1% on an organic basis, well below inflation, and a $9.7 million recovery of trade duties was recorded.
Positive Cash Flow and Shareholder Returns
Cash flow from operations was $33.9 million, with $11.2 million returned to shareholders through dividends and share repurchases.
Successful Tariff and Trade Management
ADENTRA navigated trade challenges with a price pass-through model and received a net recovery of $9.7 million in operating expenses related to trade duties.
Negative Updates
Soft Residential Construction Market
The residential construction market remains soft, with macro uncertainty affecting the U.S. trade landscape.
Increased Leverage Ratio
The leverage ratio increased to 3.0x, up from 2.4x at the start of the year, due to inventory build-up.
July Sales Decline
Average daily sales in July were tracking modestly below Q2 levels, down about 4%.
Higher Interest and Tax Expenses
Year-over-year adjusted net income decline was due to higher interest and tax expenses.
Company Guidance
During the call, ADENTRA provided a detailed overview of its second quarter 2025 performance and outlook. The company reported sales of $597 million, a 9% increase from the previous year, largely driven by the acquisition of Woolf Distributing. Adjusted EBITDA reached $54 million, and adjusted earnings per share (EPS) were $0.88. Sales in the U.S. grew by 9.3%, while Canadian sales increased by 2.8%. Gross profit rose to $130.1 million with a margin of 21.8%. Operating expenses decreased by 3.9%, aided by a $9.7 million trade duty recovery. The net income was $22.1 million or $0.89 per share, with adjusted net income at $21.9 million or $0.88 per share. Cash flow from operations was strong at $33.9 million, and $11.2 million was returned to shareholders via dividends and share buybacks. The leverage ratio was 3.0x, expected to decrease to mid-2s by year-end. The company noted that approximately 14% of its product mix is currently subject to tariffs, which could increase depending on ongoing trade investigations. Looking ahead, ADENTRA aims to sustain double-digit returns through disciplined execution and strategic M&A activities, despite facing macroeconomic challenges.

ADENTRA Financial Statement Overview

Summary
ADENTRA presents a stable financial position with moderate profitability. The income statement shows a slight revenue decline and tight net profit margins, while the balance sheet indicates effective debt management despite slow equity growth. Strong operating cash flow is offset by fluctuating free cash flow growth, necessitating strategic improvements in operational efficiency.
Income Statement
65
Positive
ADENTRA's income statement shows a mixed performance. The company experienced a slight revenue decline in the TTM period compared to the previous year, but maintained a stable gross profit margin. Net profit margins are relatively low, indicating tight cost management. The decline in EBIT and EBITDA margins suggests pressure on operational efficiency, potentially due to increased costs or pricing pressures.
Balance Sheet
70
Positive
The balance sheet reflects a stable financial position with moderate leverage. The debt-to-equity ratio has improved slightly over the years, indicating effective debt management. However, equity growth has been slow, and the equity ratio remains moderate. Return on equity has shown volatility, which may pose a risk to consistent shareholder returns.
Cash Flow
75
Positive
Cash flow analysis indicates strong operating cash flow, despite a declining free cash flow growth rate. The company has managed to maintain a healthy operating cash flow to net income ratio, suggesting efficient cash conversion from profits. However, the free cash flow to net income ratio has shown fluctuations, which could impact future investment capabilities.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.19B2.18B2.24B2.58B1.62B976.59M
Gross Profit472.81M474.06M466.10M556.75M372.91M187.81M
EBITDA165.08M169.82M161.86M343.35M184.79M90.02M
Net Income39.93M46.48M36.05M128.67M103.14M28.03M
Balance Sheet
Total Assets1.47B1.40B1.23B1.43B1.11B459.52M
Cash, Cash Equivalents and Short-Term Investments24.43M33.74M13.00M65.07M7.76M457.98K
Total Debt673.53M623.07M564.03M789.86M570.59M166.61M
Total Liabilities839.89M763.08M705.25M922.00M700.89M220.06M
Stockholders Equity633.78M634.57M526.87M506.97M414.03M239.46M
Cash Flow
Free Cash Flow93.13M133.54M226.30M199.88M-72.88M61.75M
Operating Cash Flow103.28M142.75M238.08M210.69M-65.42M64.19M
Investing Cash Flow-159.07M-147.46M-13.48M-279.47M-306.63M
Financing Cash Flow59.80M30.00M-285.99M128.61M378.85M

ADENTRA Technical Analysis

Technical Analysis Sentiment
Positive
Last Price34.86
Price Trends
50DMA
29.27
Positive
100DMA
27.94
Positive
200DMA
31.68
Positive
Market Momentum
MACD
1.25
Negative
RSI
79.53
Negative
STOCH
90.73
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:ADEN, the sentiment is Positive. The current price of 34.86 is above the 20-day moving average (MA) of 30.91, above the 50-day MA of 29.27, and above the 200-day MA of 31.68, indicating a bullish trend. The MACD of 1.25 indicates Negative momentum. The RSI at 79.53 is Negative, neither overbought nor oversold. The STOCH value of 90.73 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:ADEN.

ADENTRA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
C$857.03M11.5411.99%5.79%23.84%17.05%
73
Outperform
C$494.39M13.806.93%6.13%2.19%-48.80%
73
Outperform
C$699.79M6.9312.00%4.47%4.99%38.70%
72
Outperform
C$850.91M13.927.08%1.72%6.80%-6.80%
67
Neutral
$2.28B14.129.90%4.16%5.82%-15.76%
61
Neutral
C$1.29B50.652.78%3.77%20.53%74.96%
61
Neutral
C$7.19B-4.76-4.20%2.32%13.56%-31.48%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:ADEN
ADENTRA
34.25
-6.13
-15.18%
TSE:RUS
Russel Metals
40.62
4.08
11.18%
TSE:WJX
Wajax Corporation
22.91
0.08
0.35%
TSE:DBM
Doman Building Materials Group
9.68
3.35
52.92%
TSE:ALC
Algoma Central
17.45
3.49
25.00%
TSE:ARE
Aecon Group Inc.
20.15
2.91
16.88%

ADENTRA Corporate Events

Stock BuybackDividendsBusiness Operations and StrategyFinancial Disclosures
ADENTRA Reports Strong Q2 2025 Financial Performance Amid Market Challenges
Positive
Aug 7, 2025

ADENTRA reported strong financial results for the second quarter of 2025, with sales reaching $597.1 million, an 8.7% increase from the previous year. The company achieved a slight increase in gross margin and a significant rise in adjusted EBITDA, reflecting successful operational execution and the positive impact of its acquisition of Woolf Distributing. Despite a challenging construction market, ADENTRA effectively managed its capital, reducing debt and returning $11.2 million to shareholders through dividends and share repurchases. Looking ahead, the company plans to focus on cash generation and reducing leverage, while remaining vigilant about potential tariff impacts on its product mix.

The most recent analyst rating on (TSE:ADEN) stock is a Buy with a C$49.00 price target. To see the full list of analyst forecasts on ADENTRA stock, see the TSE:ADEN Stock Forecast page.

Financial Disclosures
ADENTRA to Announce Q2 2025 Financial Results and Host Conference Call
Neutral
Jul 14, 2025

ADENTRA Inc. has announced it will release its second quarter 2025 financial results on August 6, 2025, after market close. The following day, a conference call will be held by CEO Rob Brown and CFO Faiz Karmally to discuss the company’s financial performance, providing stakeholders with insights into ADENTRA’s operational and market positioning.

The most recent analyst rating on (TSE:ADEN) stock is a Buy with a C$51.00 price target. To see the full list of analyst forecasts on ADENTRA stock, see the TSE:ADEN Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 12, 2025